We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

By LabMedica International staff writers
Posted on 13 Jun 2025

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. More...

A Knowledge Transfer Partnership (KTP) between Aston University (Birmingham, UK) and BG Research (Kimbolton, UK) will help to further develop technology to rapidly diagnose serious and high-risk infectious diseases. CENOS, developed by BG Research, uses a portable and robust instrument that can deliver fast RT-PCR (Real Time Polymerase Chain Reaction) tests directly from unprocessed samples of blood, swab, saliva, or urine.

The platform is designed for use in remote locations, as it does not require specialist personnel or laboratory equipment and can be easily scaled in the event of an outbreak. PCR tests, used during the COVID-19 pandemic, usually require analysis in a laboratory, taking a day or more to get a result. CENOS can deliver results in around 30 minutes, enabling infected patients to be quickly isolated and treated.

CENOS can also be used for early detection of those infected but without symptoms, helping to minimize transmission and contain outbreaks. The technology is currently being piloted in veterinary settings, testing livestock for avian influenza, foot and mouth disease, Newcastle disease, and African swine fever. The KTP between Aston University and BG Research will take the company’s existing prototype and optimize its design for low-cost and high-volume manufacturing while enhancing key characteristics such as robustness, reliability, and ease of operation, assembly, and servicing.

The research will draw on expertise in the design for manufacture of medical devices from Aston University’s Engineering 4 Health (E4H) Research Centre and use the University’s advanced facilities in prototyping, materials engineering, and manufacturing processes. E4H combines research in all fields of engineering (biomedical, mechanical, chemical, electrical, and computer sciences) with health disciplines to translate innovative and emerging engineering technologies into healthcare.

The KTP will provide BG Research with a clear path towards high-volume manufacture, enabling the company to launch the CENOS instrument commercially, initially for veterinary use but, once the necessary regulations are obtained, for use in human diagnostics worldwide.

“We met with six university teams around the country, but were highly impressed with Aston University and chose them as our KTP partner,100% on merit. The University has the reach, interest, and facilities to help us get to where we need to be,” said Nelson Nazareth, managing director and chief technology officer of BG Research.

“This KTP offers us an opportunity to be involved in something with the potential to have a major impact on managing the progression of infectious diseases in countries where their burdens are most strongly felt,” added Dr. Patrick Geoghegan, senior lecturer in mechatronics and biomedical engineering and a member of the Engineering 4 Health Research Centre (E4H) at Aston University. “We hope it’s the start of a long relationship with BG Research, where we can work together to achieve their goals.”

Related Links:
Aston University
BG Research


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.